Pharma

By Jonah Comstock April 24, 2017
Medidata, a New York City-based company that offers cloud storage and data analytics services for clinical trials, announced last week its plans to acquire Mytrus, a clinical trial technology company focused on patient-focused electronic informed consent and remote trials. The terms of the acquisition were not disclosed. “The informed consent process is one of the most important parts of running...
By Jonah Comstock April 19, 2017
The first quarter of 2017 saw pharma’s visible participation in digital health steadily ramping up. From partnerships that augment digital diabetes care to infant sleep coaching collaborations, we've covered quite a range of pharma-focused news in Q1. Read on for our list of the digital undertakings of Roche, Takeda, UCB, Johnson & Johnson, and many more.  Boehringer Ingelheim partnered with...
By Heather Mack April 12, 2017
New York City-based startup Blink Health, which makes an app and online tool to help consumers find low prices on medications, has raised $90 million in Series B funding in a round led by 8VC. Previously, the company raised $75 million – also led by 8VC – bringing the company’s total funding to date at $165 million. With the latest funding, Blink Health is focusing its efforts on scaling up its...
By Tom Sullivan April 11, 2017
Amazon Web Services and Merck announced a developer competition on Monday to that plans to harness artificial intelligence for diabetics. Dubbed the Alexa Diabetes Challenge, and powered by Luminary Labs, the contest aims to incent upstarts and individual developers to create apps that harness Amazon’s Alexa voice-enabled technologies particularly for patients recently diagnosed with Type 2...
By Heather Mack April 10, 2017
Online health network PatientsLikeMe is teaming up with rare disease-focused Shire Pharmaceuticals to develop digital communities and create research opportunities for people with highly specialized, often underserved conditions. Treatment and study of rare diseases is challenging for many reasons. For one, patient populations are small and spread out around the world, and many may not have...
By Jonah Comstock April 7, 2017
A forthcoming 28-patient study in the American Heart Association's journal Stroke shows that AiCure's artificial intelligence platform led to a 50 percent improvement in adherence to oral anticoagulants. In the study, a cohort of 28 ischemic stroke survivors was followed for 12 weeks. Fifteen were assigned to the intervention group that used AiCure's software to monitor their adherence daily, and...
By Jonah Comstock April 6, 2017
Two Minneapolis-based companies – digital health care management program maker HealthFactors and medical-focused R&D firm Koronis BioMedical Technologies (KBT) – are working together to create new smart inhaler products for some undisclosed pharmaceutical partners, the company announced earlier this week. “Connected health technology, including smart inhalers, has the ability to improve...
By Heather Mack April 6, 2017
There is a basic bodily function that all people have, yet most do not want to see, hear or smell – let alone talk about. But bowel movements are an important indicator of health, and for the estimated 33 million Americans living with Chronic Idiopathic Constipation (CIC), discussion about their bathroom business is critical to finding the right treatment plan, as well as politely communicating...
By Jonah Comstock April 6, 2017
Following in the footsteps of Eli Lilly and Roche, Sanofi has quietly received FDA clearance for a smartphone app with a built-in insulin dose calculator. According to FDA documents, the app, cleared at the end of March, is called My Dose Coach. A pending trademark application gives a more in-depth description of the app, describing it as "downloadable software in the nature of a mobile...
By Heather Mack March 29, 2017
Many pharmaceutical companies are now turning to digital tools to improve medication adherence, augment clinical trials, or develop parallel therapies with digital health companies. Rare is the pharmaceutical company that wants to actively get people to stop taking their medication, but that’s exactly the aim of a new study launched by Purdue Pharmaceuticals, maker of the blockbuster and...